John van Duzer

403 total citations
11 papers, 333 citations indexed

About

John van Duzer is a scholar working on Molecular Biology, Infectious Diseases and Surgery. According to data from OpenAlex, John van Duzer has authored 11 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in John van Duzer's work include Estrogen and related hormone effects (2 papers), Veterinary medicine and infectious diseases (2 papers) and Reproductive tract infections research (2 papers). John van Duzer is often cited by papers focused on Estrogen and related hormone effects (2 papers), Veterinary medicine and infectious diseases (2 papers) and Reproductive tract infections research (2 papers). John van Duzer collaborates with scholars based in United States and Switzerland. John van Duzer's co-authors include Anat Frydman‐Marom, David M. Rothstein, Frédéric Vanhoutte, Kathleen C. M. Campbell, Jing Zhou, Andrew L. Salzman, Garry J. Southan, Csaba Szabó, Jon G. Mabley and Prakash G. Jagtap and has published in prestigious journals such as Blood, Nature Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

John van Duzer

11 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John van Duzer United States	9	119	107	60	50	40	11	333
Yoshiaki Sakaguchi Japan	10	115 1.0×	68 0.6×	47 0.8×	28 0.6×	13 0.3×	14	325
Umesh Hanumegowda United States	12	164 1.4×	25 0.2×	42 0.7×	31 0.6×	48 1.2×	22	394
Elizabeth Cauchon Canada	8	159 1.3×	91 0.9×	18 0.3×	26 0.5×	101 2.5×	11	384
Barnali Pramanik United States	6	228 1.9×	65 0.6×	120 2.0×	62 1.2×	96 2.4×	11	475
Xiaoqin Zheng China	13	156 1.3×	26 0.2×	41 0.7×	21 0.4×	35 0.9×	27	397
Shamsher S. Saini United States	14	111 0.9×	114 1.1×	39 0.7×	7 0.1×	75 1.9×	25	453
Roberta Rossi Italy	9	96 0.8×	63 0.6×	32 0.5×	35 0.7×	15 0.4×	12	314
Weiying Liu China	9	122 1.0×	90 0.8×	27 0.5×	22 0.4×	33 0.8×	28	247
George X. Song‐Zhao Canada	5	144 1.2×	36 0.3×	49 0.8×	26 0.5×	28 0.7×	6	414

Countries citing papers authored by John van Duzer

Since Specialization

Citations

This map shows the geographic impact of John van Duzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John van Duzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John van Duzer more than expected).

Fields of papers citing papers by John van Duzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John van Duzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John van Duzer. The network helps show where John van Duzer may publish in the future.

Co-authorship network of co-authors of John van Duzer

This figure shows the co-authorship network connecting the top 25 collaborators of John van Duzer. A scholar is included among the top collaborators of John van Duzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John van Duzer. John van Duzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Pryce, Kerri D., Randal A. Serafini, Aarthi Ramakrishnan, et al.. (2023). Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury. Nature Neuroscience. 26(7). 1229–1244. 12 indexed citations

Frydman‐Marom, Anat, et al.. (2019). Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers. Clinical Pharmacology in Drug Development. 8(8). 984–994. 58 indexed citations

Niesvizky, Rubén, Paul G. Richardson, Nashat Gabrail, et al.. (2015). ACY-241, a Novel, HDAC6 Selective Inhibitor: Synergy with Immunomodulatory (IMiD®) Drugs in Multiple Myeloma (MM) Cells and Early Clinical Results (ACE-MM-200 Study). Blood. 126(23). 3040–3040. 19 indexed citations

Rothstein, David M., et al.. (2008). Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization. The Journal of Antibiotics. 61(8). 485–488. 2 indexed citations

Rothstein, David M., John van Duzer, Andrew Sternlicht, & Steven C. Gilman. (2007). Rifalazil and Other Benzoxazinorifamycins in the Treatment of Chlamydia‐Based Persistent Infections. Archiv der Pharmazie. 340(10). 517–529. 13 indexed citations

Rothstein, David M., Angelia A. Doye, Judith K. Gwathmey, et al.. (2006). Efficacy of Novel Rifamycin Derivatives against Rifamycin-Sensitive and -Resistant Staphylococcus aureus Isolates in Murine Models of Infection. Antimicrobial Agents and Chemotherapy. 50(11). 3658–3664. 14 indexed citations

Murphy, Christopher K., Steve Mullin, Marcia S. Osburne, et al.. (2006). In Vitro Activity of Novel Rifamycins against Rifamycin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 50(3). 827–834. 36 indexed citations

Suchland, Robert J., et al.. (2005). Activities of Rifamycin Derivatives against Wild-Type and rpoB Mutants of Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy. 49(9). 3974–3976. 9 indexed citations

Esser, Ronald E., Carol Berry, Zhengming Du, et al.. (2005). Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2. British Journal of Pharmacology. 144(4). 538–550. 100 indexed citations

10.

Jagtap, Prakash G., Erkan Baloglu, Garry J. Southan, et al.. (2005). Discovery of Potent Poly(ADP-ribose) Polymerase-1 Inhibitors from the Modification of Indeno[1,2-c]isoquinolinone. Journal of Medicinal Chemistry. 48(16). 5100–5103. 69 indexed citations

11.

Kimble, Earl F., Timothy J. Kowalski, Philip J. Peters, et al.. (1995). CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action. Inflammation Research. 44(S2). S147–S148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact